Carcinogenesis, Vol. 21, No. 11, 1935-1940,
November 2000
© 2000 Oxford University Press
Cancer Biology |
Expression of ß-catenin and full-length APC protein in normal and neoplastic colonic tissues
Department of Medicine and
1 Department of Pathology, University of Colorado Health Sciences Center, Denver, CO 80262 and Department of Veterans Affairs Medical Center, Denver, CO 80220, USA
Mutations of the APC gene are thought to be early events in the process of colorectal carcinogenesis. Although the complete function(s) of the APC gene product is not known, it has been shown that the APC protein interacts with ß-catenin in a multi-protein complex to regulate the level of expression of ß-catenin. Loss of normal APC protein function can lead to an accumulation of ß-catenin in the cytosol and the nucleus. Immunohistochemical methods were used to determine the relationship between APC and ß-catenin protein expression in human colonic tissues (150 normal, 9 hyperplastic, 58 adenomas and 83 carcinomas) and 12 paired samples of normal and cancer tissue in mouse colon. In all samples of normal human and mouse colonic mucosa and in human hyperplastic polyps both APC and ß-catenin immunoreactivity were present in colonocytes. APC expression was cytoplasmic, with maximal immunoreactivity in the goblet cells. ß-Catenin expression was predominantly localized to the plasma membrane, with no nuclear immunoreactivity. APC immunoreactivity was absent in all of the mouse adenocarcinomas and 83% of the human colon cancers. All of the human and mouse carcinomas had nuclear and cytoplasmic ß-catenin expression. In contrast, only 29% of the 58 colonic adenomas were completely negative for APC immunoreactivity. Regardless of the presence or absence of APC, all of the adenomas had cytoplasmic and nuclear ß-catenin immunoreactivity. Many colonic adenomas retain expression of full-length APC protein whereas it is usually lost in colorectal cancers. Regardless of the status of APC protein expression, ß-catenin protein was found in the cytoplasm and nucleus of all neoplastic colonic mucosa. The dissociation between loss of expression of APC and accumulation of ß-catenin in the nucleus suggests that inactivation of both alleles of the APC gene may not be required for ß-catenin nuclear accumulation in colonic adenomas.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Zell, A. Ziogas, N. Ignatenko, J. Honda, N. Qu, A. S. Bobbs, S. L. Neuhausen, E. W. Gerner, and H. Anton-Culver Associations of a Polymorphism in the Ornithine Decarboxylase Gene with Colorectal Cancer Survival Clin. Cancer Res., October 1, 2009; 15(19): 6208 - 6216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hubner, K. R. Muir, J.-F. Liu, R. F.A. Logan, M. J. Grainge, R. S. Houlston, and Members of the UKCAP Consortium Ornithine Decarboxylase G316A Genotype Is Prognostic for Colorectal Adenoma Recurrence and Predicts Efficacy of Aspirin Chemoprevention Clin. Cancer Res., April 15, 2008; 14(8): 2303 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Tranah, E. Giovannucci, J. Ma, C. Fuchs, and D. J. Hunter APC Asp1822Val and Gly2502Ser Polymorphisms and Risk of Colorectal Cancer and Adenoma Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Jansson, A. Are, G. Greicius, I-C. Kuo, D. Kelly, V. Arulampalam, and S. Pettersson The Wnt/{beta}-catenin signaling pathway targets PPAR{gamma} activity in colon cancer cells PNAS, February 1, 2005; 102(5): 1460 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tanaka, R. Suzuki, H. Kohno, S. Sugie, M. Takahashi, and K. Wakabayashi Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess {beta}-catenin gene mutations and increases immunoreactivity for {beta}-catenin, cyclooxygenase-2 and inducible nitric oxide synthase Carcinogenesis, January 1, 2005; 26(1): 229 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.C. Sills, H.L. Hong, G. Flake, C. Moomaw, N. Clayton, G.A. Boorman, J. Dunnick, and T.R. Devereux o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis Carcinogenesis, April 1, 2004; 25(4): 605 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Pretlow, W. Edelmann, R. Kucherlapati, T. G. Pretlow, and L. H. Augenlicht Spontaneous Aberrant Crypt Foci in Apc1638N Mice with a Mutant Apc Allele Am. J. Pathol., November 1, 2003; 163(5): 1757 - 1763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Rice, J. Kelloff, H. Sullivan, L. J. Driggers, K. S. Beard, S. Kuwada, G. Piazza, and D. J. Ahnen Sulindac metabolites induce caspase- and proteasome-dependent degradation of {beta}-catenin protein in human colon cancer cells Mol. Cancer Ther., September 1, 2003; 2(9): 885 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Martinez, T. G. O'Brien, K. E. Fultz, N. Babbar, H. Yerushalmi, N. Qu, Y. Guo, D. Boorman, J. Einspahr, D. S. Alberts, et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene PNAS, June 24, 2003; 100(13): 7859 - 7864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Araki, S. Okamura, S. P. Hussain, M. Nagashima, P. He, M. Shiseki, K. Miura, and C. C. Harris Regulation of Cyclooxygenase-2 Expression by the Wnt and Ras Pathways Cancer Res., February 1, 2003; 63(3): 728 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Roberts, L. Min, M. K. Washington, S. J. Olsen, S. H. Settle, R. J. Coffey, and D. W. Threadgill Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis PNAS, January 24, 2002; (2002) 32678499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Chung, E. Provost, E. P. Kielhorn, L. A. Charette, B. L. Smith, and D. L. Rimm Tissue Microarray Analysis of {beta}-Catenin in Colorectal Cancer Shows Nuclear Phospho-{beta}-catenin Is Associated with a Better Prognosis Clin. Cancer Res., December 1, 2001; 7(12): 4013 - 4020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. P. Hao, T. G. Pretlow, J. S. Rao, and T. P. Pretlow {beta}-Catenin Expression Is Altered in Human Colonic Aberrant Crypt Foci Cancer Res., November 1, 2001; 61(22): 8085 - 8088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-M. Shih, T.-L. Wang, G. Traverso, K. Romans, S. R. Hamilton, S. Ben-Sasson, K. W. Kinzler, and B. Vogelstein Top-down morphogenesis of colorectal tumors PNAS, February 15, 2001; (2001) 51629398. [Abstract] [Full Text]
|
|
|
|
|
|
R. B. Roberts, L. Min, M. K. Washington, S. J. Olsen, S. H. Settle, R. J. Coffey, and D. W. Threadgill Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis PNAS, February 5, 2002; 99(3): 1521 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-M. Shih, T.-L. Wang, G. Traverso, K. Romans, S. R. Hamilton, S. Ben-Sasson, K. W. Kinzler, and B. Vogelstein Top-down morphogenesis of colorectal tumors PNAS, February 27, 2001; 98(5): 2640 - 2645. [Abstract] [Full Text] [PDF]
|
|